Three Molecules, Very Different Roles
When people talk about omega-3s, they often treat the category as a single nutrient. In practice, the term covers three distinct fatty acids - alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) - each with different origins, biological pathways, and levels of evidence behind them.
The three main types are ALA, EPA, and DHA.
ALA comes primarily from plant-based sources, while EPA and DHA are obtained mainly from fatty fish and marine organisms. That distinction sounds simple, but it carries significant practical implications - particularly for people who rely on plant sources alone and assume their omega-3 intake is covered.
What ALA Can and Cannot Do
Flaxseeds, walnuts, chia seeds, and hemp hearts are all rich in ALA. They’re widely promoted as omega-3 foods, and in one sense that’s accurate - they do provide the parent omega-3 fatty acid. The complication is what happens after you eat them.
ALA converts poorly to EPA (under 8%) and to DHA (under 4%), and conversion efficiency varies by sex, genetics, disease state, and omega-6 intake - with premenopausal women generally converting at higher rates than men. In less favorable dietary conditions, the numbers drop further: with a background diet high in saturated fat, conversion to EPA is roughly 6% and to DHA roughly 3.8%, and a diet rich in omega-6 PUFAs may reduce that conversion by an additional 40 to 50%.
This matters because omega-6 and omega-3 fatty acids compete for the same enzymes in the conversion process. Both are polyunsaturated fatty acids, but the typical diet delivers considerably more omega-6 than omega-3 - an imbalance thought to work against omega-3 metabolism.
The upshot is that even generous ALA intake from plant foods doesn’t reliably translate into meaningful blood levels of EPA or DHA. DHA and EPA have a well-established blood triglyceride-lowering effect, while ALA does not.
Anti-thrombotic effects - including inhibition of platelet aggregation - have been very weak or nonexistent when ALA is compared to DHA and EPA.
One 2025 study did find that under carefully optimized dietary conditions, ALA from flaxseed oil raised long-chain omega-3 levels more than was previously observed in typical settings. However, even with flaxseed oil supplementation substantially improving omega-3 status across dietary patterns, it did not eliminate absolute differences in EPA and DHA levels between vegans and omnivores.
The Cardiovascular Evidence: Encouraging but Mixed
EPA and DHA are associated with anti-inflammatory and anti-thrombotic properties, lower plasma triglycerides and LDL cholesterol, and improvements in vascular and endothelial function. These properties drove decades of enthusiasm about omega-3s and heart health - enthusiasm that has since run into a more complicated body of trial data.
Earlier secondary prevention trials from the 1980s through the early 2000s showed a cardioprotective effect of fish consumption and omega-3 supplementation, and meta-analyses of observational studies reported an inverse relationship between fish consumption and fatal coronary heart disease. More recent supplementation trials, however, produced inconsistent results.
Much controversy has circulated due to discordant results among studies and even meta-analyses, and in 2018, three large randomized trials were released with differing findings about the benefits of omega-3 therapy.
The trial that used a higher dose - 4 g/day of highly purified EPA - found a statistically significant reduction in cardiovascular events, leading to proposals that insufficient dosing and the concurrent use of other effective medications may help explain the conflicting results seen across controlled trials.
The American Heart Association does not recommend omega-3 supplements for people who are not at high risk of cardiovascular disease. That position reflects the current evidence: the strongest signal for supplementation appears in higher-risk individuals, not the general population. Eating fish, on the other hand, shows a more consistent association with reduced cardiovascular risk than taking fish oil capsules - a difference that may relate to dose, matrix effects, or other nutrients present in whole fish.
Brain, Mood, and Cognitive Function
EPA and DHA are considered important for neurodevelopment and for improving metabolic and immune processes. DHA accumulates specifically in brain tissue - it is the predominant fatty acid in neural membranes - though the clinical implications of this for adults are still being actively studied.
Some research suggests that omega-3s may help protect against cognitive decline, Alzheimer’s disease, and dementia, and may have a positive effect on gradual memory loss linked to aging
- though evidence here remains preliminary and drawn largely from observational data rather than intervention trials.
The mood and mental health picture is similarly mixed. Some research suggests omega-3 supplements may help improve symptoms of depression and anxiety, with a review of 23 clinical trials suggesting that a dosage of 2 g per day or more may help reduce anxiety symptoms in some populations. These findings are worth noting, but a review of trials with varying designs and populations doesn’t establish a clear clinical recommendation.
Plant-Based Diets and the Algal Alternative
EPA and DHA cannot be synthesized adequately by the body and must be obtained through dietary sources - primarily fish and fish oil supplements. For people who don’t eat fish, this creates a practical gap.
To compensate for the absence of marine sources, vegetarians and vegans are advised to combine regular intake of ALA-rich foods such as flaxseeds and walnuts with algae-derived EPA and DHA supplements to achieve adequate long-chain omega-3 intake.
This is where algal oil becomes relevant. Fish don’t synthesize EPA and DHA themselves - they accumulate them by eating marine microalgae. Going directly to the algal source cuts out the intermediary. Plant-based omega-3 supplements from algal oil may provide varying amounts of DHA, and some contain EPA as well.
According to a small study, the bioavailability of DHA from algal oil was comparable to that from cooked salmon in that study’s population
- a notable finding, though the limited size of that study warrants caution about drawing firm conclusions.
Getting the Most From Food Sources
Whole food marine sources - salmon, mackerel, sardines, anchovies, herring - remain the most reliable dietary pathway to meaningful EPA and DHA levels. They deliver these fatty acids in a readily usable form without relying on a metabolic conversion that varies widely between individuals.
Formulations of omega-3 dietary supplements vary widely, so checking product labels to determine the actual types and amounts of omega-3s present is important
- many supplements list total fish oil weight, which may obscure the actual EPA and DHA content. A product providing 1,000 mg of fish oil may contain considerably less than 1,000 mg of combined EPA and DHA.
For people building dietary habits around omega-3s, the form the fatty acid arrives in - already as EPA and DHA, or as ALA that must be converted - determines how much of it the body can actually put to work. Eating two to three servings of fatty fish per week remains one of the more direct ways to maintain adequate EPA and DHA levels without requiring any enzymatic conversion at all.
